Netherlands vs Zimbabwe: Access to anti-retroviral drugs, male
Netherlands
89.0%
in 2023
Zimbabwe
89.0%
in 2024
Netherlands rank
17th
Zimbabwe rank
17th
Access to anti-retroviral drugs, male over time
- Netherlands
- Zimbabwe
How they compare
Netherlands currently reports 89.0% against 89.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Netherlands ahead.
Netherlands ranks 17th and Zimbabwe ranks 17th of 141 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.8% | 4.1% | 46.7% | Netherlands |
| 2010s | 76.8% | 52.9% | 23.9% | Netherlands |
| 2020s | 88.2% | 88.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Netherlands or Zimbabwe?
- Netherlands, at 89.0% against 89.0% in Zimbabwe as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Netherlands and Zimbabwe?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Zimbabwe?
- 24 years are reported by both, from 2000 to 2023.
- How do Netherlands and Zimbabwe rank globally for access to anti-retroviral drugs, male?
- Netherlands ranks 17th and Zimbabwe ranks 17th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.